FDA “Broad Agency Announcement” To Fund Generic, Clinical Design Research
Agency expects to provide $200,000 to $50 million on a wide range of research proposals to support regulatory science and innovation.
You may also be interested in...
GPhA recommends FDA deploy user fee research money to look at shortage risk assessment and mitigation strategies, while the trade group continues to look for a product to fit its own shortage prediction model.
FDA Commissioner takes a softer tone in repeating the message that quality must improve in the generics industry, saying the reward may manifest in inspection policy.
AstraZeneca will reacquire Allergan's investigational IL-23 inhibitor brazikumab, and Nestle is to buy its GI drug Zenpep, which had nine-month revenue of $208m.